本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

XILIO THERAPEUTICS, INC.

0.7310
+0.02102.96%
盘后1.230.4990+68.26%19:59 EDT
成交量:1,098.14万
成交额:914.61万
市值:3,784.66万
市盈率:-0.88
高:0.7499
开:0.7100
低:0.6975
收:0.7100
数据加载中...
2022/01/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/06

重要事件披露

8-K - Current report
2021/12/02

重要事件披露

8-K - Current report
2021/12/02

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/05

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/03

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/10/27

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/26

重要事件披露

8-K - Current report
2021/10/25

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/10/20

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/19

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/19

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/18

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/18

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/01

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/10/01

SEC问询函

CORRESP [Cover] - Correspondence